- Home
- MOLN vs MED Comparison
MOLN vs MED Comparison
Compare MOLN & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MOLN | MED |
|---|---|---|
| Founded | 2004 | 1980 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Packaged Foods |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.2M | 120.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | MOLN | MED |
|---|---|---|
| Price | $4.23 | $11.13 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $3.75 | ★ $16.50 |
| AVG Volume (30 Days) | 4.2K | ★ 288.1K |
| Earning Date | 02-11-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $429,695,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $999.99 | N/A |
| P/E Ratio | ★ N/A | $457.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.36 | $10.36 |
| 52 Week High | $5.91 | $18.59 |
Technical Indicators
Market Signals| Indicator | MOLN | MED |
|---|---|---|
| Relative Strength Index (RSI) | 49.23 | 42.64 |
| Support Level | $4.20 | $11.07 |
| Resistance Level | $4.60 | $12.40 |
| Average True Range (ATR) | 0.18 | 0.42 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 45.59 | 18.01 |
Price Performance
Historical ComparisonAbout MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.